未登录

J

Joseph C. Glorioso

university of pittsburgh

H指数:75

被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications

更正：HSV-1复制缺陷型载体中的基因突变：其在基因治疗应用中的安全性意义

IF4.5

2026-04-200

OAAI

Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications

HSV-1复制缺陷型载体的基因突变：对基因治疗应用中其安全性的影响

IF4.5

2025-09-280

OAAI

rdHSV-CA8 non-opioid analgesic gene therapy decreases somatosensory neuronal excitability by activating Kv7 voltage-gated potassium channels

FRONTIERS IN MOLECULAR NEUROSCIENCE

IF3.8

2024-05-093

OAAI

Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment

MOLECULAR THERAPY-ONCOLYTICS

IF0

2021-09-014

OAAI

Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability

MOLECULAR THERAPY-ONCOLYTICS

IF0

2020-09-0122

OAAI

GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival

MOLECULAR THERAPY-ONCOLYTICS

IF0

2019-12-0135

OAAI

Cooperation of oncolytic virotherapy with VEGF-neutralizing antibody treatment in IDH wildtype glioblastoma depends on MMP9

IF13.4

2019-08-158

OAAI

Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma

IF6.1

2019-07-1129

OA

Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression

JOURNAL OF VIROLOGY

IF3.8

2018-09-0113

OA

ONCR-1, a novel herpes simplex virus expressing MMP9 and ULBP3 transgenes, evokes potent oncolysis and development of antitumor immune responses

CANCER RESEARCH

IF16.6

2018-07-011

PRE

Engineered HSV vector achieves safe long-term transgene expression in the central nervous system

SCIENTIFIC REPORTS

IF3.9

2017-05-0429

OAAI

GENE THERAPY WITH REPLICATION-DEFICIENT HERPES SIMPLEX VIRUS (HSV) VECTORS ENCODING PORELESS TRPV1 (PL) OR PROTEIN PHOSPHATASE 1α (PP1α) IN A RAT MODEL OF HYDROGEN PEROXIDE-INDUCED CYSTITIS

JOURNAL OF UROLOGY

IF6.8

2017-04-010

PREAI

MO RPHOLOGICAL CHANGES OF DIFFERENT POPULATIONS OF BLADDER AFFERENT NEURONS DETECTED BY HERPES SIMPLEX VIRUS (HSV) VECTORS WITH CELL TYPE-SPECIFIC PROMOTERS IN MICE WITH SPINAL CORD INJURY

JOURNAL OF UROLOGY

IF6.8

2017-04-010

PREAI

Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus

JOURNAL OF VIROLOGY

IF3.8

2016-12-1510

OAAI

Retargeting of herpes simplex virus (HSV) vectors

CURRENT OPINION IN VIROLOGY

IF5.1

2016-12-0135

OAAI

Arming a Tumor Targeted Oncolytic HSV Vector with MMP9 for Enhanced Distribution and Killing Activity

MOLECULAR THERAPY

IF12

2016-05-010

OAAI

HSV Vectors Retargeted for Infection of TrkA Receptor-Bearing, Pain-Sensing C-Fibers

MOLECULAR THERAPY

IF12

2016-05-010

OAAI

Replication-Defective HSV Vector Development for Targeted Gene Delivery

MOLECULAR THERAPY

IF12

2016-05-010

OAAI

HERPES SIMPLEX VIRUS (HSV) VECTOR-MEDIATED GENE DELIVERY OF PORELESS TRPV1 CHANNELS OR PROTEIN PHOSPHATE 1α (PP1α) REDUCES BLADDER OVERACTIVITY AND NOCICEPTION IN RAT MODEL OF CYSTITIS INDUCED BY HYDROGEN PEROXIDE

JOURNAL OF UROLOGY

IF6.8

2016-04-010

OA

Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma

抑制组蛋白去乙酰化酶6增强胶质瘤中溶瘤病毒的复制

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2015-10-2062

OA